AU4377397A - Novel therapeutically active adenosine derivatives - Google Patents

Novel therapeutically active adenosine derivatives

Info

Publication number
AU4377397A
AU4377397A AU43773/97A AU4377397A AU4377397A AU 4377397 A AU4377397 A AU 4377397A AU 43773/97 A AU43773/97 A AU 43773/97A AU 4377397 A AU4377397 A AU 4377397A AU 4377397 A AU4377397 A AU 4377397A
Authority
AU
Australia
Prior art keywords
therapeutically active
adenosine derivatives
novel therapeutically
active adenosine
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43773/97A
Inventor
Lars Knutsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU4377397A publication Critical patent/AU4377397A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU43773/97A 1996-10-14 1997-10-02 Novel therapeutically active adenosine derivatives Abandoned AU4377397A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK1136/96 1996-10-14
DK113696 1996-10-14
PCT/DK1997/000423 WO1998016539A1 (en) 1996-10-14 1997-10-02 Novel therapeutically active adenosine derivatives

Publications (1)

Publication Number Publication Date
AU4377397A true AU4377397A (en) 1998-05-11

Family

ID=8101427

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43773/97A Abandoned AU4377397A (en) 1996-10-14 1997-10-02 Novel therapeutically active adenosine derivatives

Country Status (3)

Country Link
AU (1) AU4377397A (en)
WO (1) WO1998016539A1 (en)
ZA (1) ZA978948B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU44900A (en) 1998-01-31 2003-01-31 Glaxo Group Limited 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
EP1090022B1 (en) 1998-06-23 2003-08-06 Glaxo Group Limited 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
GB9813554D0 (en) * 1998-06-23 1998-08-19 Glaxo Group Ltd Chemical compounds
GB0105469D0 (en) * 2001-03-06 2001-04-25 Glaxo Group Ltd Medicaments
GB0106867D0 (en) 2001-03-20 2001-05-09 Glaxo Group Ltd Process
US7414036B2 (en) 2002-01-25 2008-08-19 Muscagen Limited Compounds useful as A3 adenosine receptor agonists
NZ538590A (en) * 2002-08-15 2006-10-27 Cv Therapeutics Inc Partial and full agonists of A1 adenosine receptors
PE20060272A1 (en) 2004-05-24 2006-05-22 Glaxo Group Ltd (2R, 3R, 4S, 5R, 2'R, 3'R, 4'S, 5'S) -2.2 '- {TRANS-1,4-CYCLOHEXANODIYLBIS- [IMINO (2 - {[2- (1-METHYL- 1H-IMIDAZOL-4-IL) ETHYL] AMINO} -9H-PURIN-6,9-DIYL)]} BIS [5- (2-ETHYL-2H-TETRAZOLE-5-IL) TETRAHYDRO-3,4-FURANODIOL] AS AN A2A AGONIST
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
HUT61567A (en) * 1990-12-07 1993-01-28 Sandoz Ag Process for producing new pharmaceutical compositions comprising 2'-o-alkyladenosine derivatives and for producing 6-cyclohexyl-2'-o-methyladenosinehydrate
US5432164A (en) * 1991-10-24 1995-07-11 Novo Nordisk A/S C2,N6 -disubstituted adenosine derivatives
US5589467A (en) * 1993-09-17 1996-12-31 Novo Nordisk A/S 2,5',N6-trisubstituted adenosine derivatives

Also Published As

Publication number Publication date
ZA978948B (en) 1998-04-14
WO1998016539A1 (en) 1998-04-23

Similar Documents

Publication Publication Date Title
AU4665596A (en) Pyrazolylbenzoyl derivatives
AU1756897A (en) Avermectin formulation
AU7626596A (en) Oxymethoxy-3-aryl-pyrone derivatives
AU4086296A (en) Indolepiperidine derivatives
AU1195897A (en) Heteroarylcarboxamide derivatives
AU1735497A (en) Sulfonylureidopyrazole derivatives
AU7053296A (en) Purin-6-one derivatives
AU2186797A (en) Pharmaceutically useful compounds
AU4875296A (en) Isoxazolyl-benzoyl derivatives
AU3867997A (en) Chromene-3-carboxylate derivatives
AU7738098A (en) Novel tetrahydrobenzindolone derivatives
AU2956097A (en) Alkylaminobenzothiazole and -benzoxazole derivatives
AU5763596A (en) 2-ureido-benzamide derivatives
EP1008579A3 (en) Cyclopentenebutanol derivatives
AU6191796A (en) Sulfonyl- or sulfinylbenzoylguanidine derivatives
AU4962097A (en) 2-methoxyphenylpiperazine derivatives
AU7084796A (en) Diarylalkenylamine derivatives
AU4377397A (en) Novel therapeutically active adenosine derivatives
AU1595997A (en) Thienoxazinone derivatives useful as antiviral agents
AU1793197A (en) Pyrazole-4-yl-hetaroyl derivatives
AU4547796A (en) Hexahydropyrazinoquinoline derivatives
AU5052296A (en) 4-indolylpiperazinyl derivatives
AU4622597A (en) Novel pyranoside derivatives
AU3685097A (en) N-benzylazolium derivatives
AU4211296A (en) 4-aminobenzoylguanidine derivatives